Company profile
Antegenes company profile
Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detection measures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
Business identity
- Website
- https://antegenes.com/
- Contact email
- [email protected]
- Phone number
- +372-5377-8141
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2018-01-01
Headquarters
- Headquarters
- Pedernales, Manabí, Ecuador
- Postal code
- 50603
- Country code
- EC
- Continent
- South America